This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SODIUM CHLORIDE INJ
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of 2 boxes of Sodium Chloride Injection, USP, 0.9%, 1000 mL, 14’s per box, with a unit of issue defined as a box (BX), totaling 28 individual units. The item is regulated by the FDA and must meet stringent technical and quality requirements referenced through "R" and "I" numbers in the DLA Master List of Technical and Quality Requirements. The product must have a non-extendable 36-month shelf life at the time of delivery, conforming to Type I (Code Q) requirements, and must be stored at medical controlled room temperature. Packaging and marking must strictly adhere to MIL-STD-2073-1E and the Medical Marking Standard No. 1, superseding MIL-STD-129 for all medical acquisitions, and include appropriate barcoding. Hazardous material labeling must comply with applicable federal statutes including the Hazard Communication Standard, Federal Food, Drug, and Cosmetic Act, and others, with pre-award submission of labels and MSDS required for any materials not explicitly exempted. The contractor is Baxter Healthcare Corporation with part number 2B1324X, and delivery is due within 20 days after order placement to two designated locations: Fort Bragg, NC and Eglin AFB, FL, under FOB Destination terms, meaning the contractor bears all transportation costs and risks until receipt at the destination. Inspection and acceptance occur solely at the delivery point by government personnel. The contract is issued under solicitation SPE2DP-26-T-3460, posted on May 18, 2026, with a response deadline of May 26, 2026, and is administered by the Department of Defense’s Medical Supply Chain Pharm FSA through Contracting Officer Lawrence Garnett. Invoicing must be submitted electronically via WAWF, with payment routed through specified DoDAACs, and accounting data will be defined in the resulting award. Offerors must disclose UEI and CAGE codes, affirm small business status if applicable, and comply with all representations under SAM.gov, including socioeconomic certifications and prohibitions on defense telecommunications equipment from restricted entities. The contract incorporates numerous FAR and DFARS clauses covering trafficking in persons, employment eligibility, sustainable products, cyber safeguarding, whistleblower rights, and prohibitions on hazardous substances such as hexavalent chromium. No contract value or unit pricing is specified in the solic
General Info
Agency
NAICS
Place of Performance
PR: 7016814967 PRLI: 0001 CONT’D, EGLIN AFB, FL, 32542-6622, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
SODIUM CHLORIDE INJECTION, USP, 0.9%, 1000 ML, 14'S
UNIT OF ISSUE PG, Store at medical controlled room temperature.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 BX = 14 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORPORATION 1G026 P/N 2B1324X
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016814967 0001 BX 2.000
NSN/MATERIAL:6505000836544
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
SPE2DP-26-T-3460
SECTION B
PR: 7016814967 PRLI: 0001 CONT’D
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-083-6544 Quantity: 2 BX Purchase Request: 7016814928QTY: 2 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
